Payment overview · 2025
General Payments
$143.05
6 reported records · 2 companies
Healthcare provider profile · identity verified
Jong Gil Oh, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FARMINGTON, CT · NPI 1245296573
Verified facts
What the public records show
CMS Open Payments records show Jong Gil Oh, MD received $143.05 in general payments during 2025 across 6 reported records.
Neurocrine BioSciences, Inc. accounted for 84.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Ingrezza by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $120.16 | 84.0% | 5 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $22.89 | 16.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $143.05 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $120.16 | 5 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $22.89 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1889 | 245 |
| Trazodone Hcl | Trazodone Hcl | 1622 | 220 |
| Amlodipine Besylate | Amlodipine Besylate | 992 | 136 |
| Levothyroxine Sodium | Levothyroxine Sodium | 783 | 92 |
| Furosemide | Furosemide | 769 | 123 |
| Gabapentin | Gabapentin | 758 | 112 |
| Eliquis | Apixaban | 708 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 643 | 88 |
| Lisinopril | Lisinopril | 634 | 80 |
| Quetiapine Fumarate | Quetiapine Fumarate | 602 | 79 |
| Mirtazapine | Mirtazapine | 556 | 82 |
| Metoprolol Tartrate | Metoprolol Tartrate | 517 | 75 |
| Divalproex Sodium | Divalproex Sodium | 485 | 62 |
| Xarelto | Rivaroxaban | 477 | 29 |
| Metoprolol Succinate | Metoprolol Succinate | 424 | 79 |
| Omeprazole | Omeprazole | 421 | 74 |
| Metformin Hcl | Metformin Hcl | 419 | 62 |
| Risperidone | Risperidone | 419 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 416 | 64 |
| Sertraline Hcl | Sertraline Hcl | 397 | 55 |
| Potassium Chloride | Potassium Chloride | 384 | 51 |
| Levetiracetam | Levetiracetam | 327 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 320 | 68 |
| Olanzapine | Olanzapine | 318 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 275 | 37 |
| Finasteride | Finasteride | 273 | 38 |
| Latanoprost | Latanoprost | 247 | 37 |
| Donepezil Hcl | Donepezil Hcl | 246 | 32 |
| Famotidine | Famotidine | 242 | 34 |
| Farxiga | Dapagliflozin Propanediol | 237 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 235 | 34 |
| Losartan Potassium | Losartan Potassium | 231 | 39 |
| Carvedilol | Carvedilol | 226 | 29 |
| Tramadol Hcl | Tramadol Hcl | 221 | 47 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 215 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 212 | 26 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 210 | 35 |
| Warfarin Sodium | Warfarin Sodium | 207 | suppressed |
| Myrbetriq | Mirabegron | 205 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 204 | 33 |
| Tradjenta | Linagliptin | 182 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 181 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 174 | 47 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 170 | 76 |
| Ropinirole Hcl | Ropinirole Hcl | 170 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 169 | 25 |
| Enulose | Lactulose | 165 | 19 |
| Lactulose | Lactulose | 163 | 27 |
| Baclofen | Baclofen | 158 | 29 |
| Spironolactone | Spironolactone | 154 | 24 |
| Jardiance | Empagliflozin | 147 | 22 |
| Humalog | Insulin Lispro | 146 | 24 |
| Simvastatin | Simvastatin | 137 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 135 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 19 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 132 | 112 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 131 | 50 |
| Trulicity | Dulaglutide | 130 | 16 |
| Lorazepam | Lorazepam | 129 | 50 |
| Gemtesa | Vibegron | 127 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 124 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 121 | 21 |
| Divalproex Sodium Er | Divalproex Sodium | 121 | 13 |
| Januvia | Sitagliptin Phosphate | 117 | 11 |
| Memantine Hcl | Memantine Hcl | 115 | 20 |
| Topiramate | Topiramate | 112 | 14 |
| Torsemide | Torsemide | 109 | 18 |
| Alendronate Sodium | Alendronate Sodium | 108 | 12 |
| Clonidine Hcl | Clonidine Hcl | 108 | 13 |
| Oxcarbazepine | Oxcarbazepine | 107 | 11 |
| Prednisone | Prednisone | 105 | 38 |
| Clozapine | Clozapine | 104 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 104 | 22 |
| Aripiprazole | Aripiprazole | 100 | 11 |
| Lithium Carbonate | Lithium Carbonate | 99 | suppressed |
| Nystatin | Nystatin | 96 | 34 |
| Buspirone Hcl | Buspirone Hcl | 95 | 19 |
| Midodrine Hcl | Midodrine Hcl | 95 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 91 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 91 | 11 |
| Ibuprofen | Ibuprofen | 89 | 24 |
| Allopurinol | Allopurinol | 87 | 16 |
| Cephalexin | Cephalexin | 86 | 46 |
| Fenofibrate | Fenofibrate,micronized | 85 | 11 |
| Lubiprostone | Lubiprostone | 85 | suppressed |
| Ezetimibe | Ezetimibe | 84 | 11 |
| Haloperidol | Haloperidol | 84 | 13 |
| Bupropion Xl | Bupropion Hcl | 82 | 18 |
| Montelukast Sodium | Montelukast Sodium | 81 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 79 | 15 |
| Lamotrigine | Lamotrigine | 78 | suppressed |
| Entresto | Sacubitril/Valsartan | 77 | suppressed |
| Methocarbamol | Methocarbamol | 77 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 76 | 40 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 76 | 12 |
| Metformin Hcl Er | Metformin Hcl | 75 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | 15 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 18 |
| Humalog Kwikpen U-100 | Insulin Lispro | 70 | suppressed |
| Alprazolam | Alprazolam | 69 | 12 |
| Morphine Sulfate | Morphine Sulfate | 68 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 68 | 17 |
| Mounjaro | Tirzepatide | 65 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 64 | 18 |
| Brimonidine Tartrate | Brimonidine Tartrate | 62 | suppressed |
| Bumetanide | Bumetanide | 62 | suppressed |
| Perphenazine | Perphenazine | 62 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 61 | 24 |
| Propranolol Hcl | Propranolol Hcl | 59 | suppressed |
| Olanzapine Odt | Olanzapine | 58 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 58 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 56 | suppressed |
| Linzess | Linaclotide | 56 | suppressed |
| Xifaxan | Rifaximin | 56 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 54 | suppressed |
| Clonazepam | Clonazepam | 53 | 13 |
| Timolol Maleate | Timolol Maleate | 53 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 52 | 27 |
| Carbamazepine | Carbamazepine | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | suppressed |
| Digoxin | Digoxin | 49 | suppressed |
| Paliperidone Er | Paliperidone | 49 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 48 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 16 |
| Restasis | Cyclosporine | 46 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 44 | 18 |
| Levemir | Insulin Detemir | 44 | suppressed |
| Meloxicam | Meloxicam | 44 | 15 |
| Atenolol | Atenolol | 43 | suppressed |
| Insulin Lispro | Insulin Lispro | 43 | 12 |
| Ramelteon | Ramelteon | 43 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Budesonide | Budesonide | 42 | suppressed |
| Ondansetron Odt | Ondansetron | 42 | 24 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 42 | suppressed |
| Fenofibrate | Fenofibrate | 41 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 41 | suppressed |
| Colchicine | Colchicine | 40 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 40 | suppressed |
| Brilinta | Ticagrelor | 39 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 39 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 25 |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 24 |
| Dorzolamide Hcl | Dorzolamide Hcl | 37 | suppressed |
| Erythromycin | Erythromycin Base | 37 | 13 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 37 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 36 | 36 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 35 | 18 |
| Incruse Ellipta | Umeclidinium Bromide | 35 | suppressed |
| Methimazole | Methimazole | 35 | suppressed |
| Pregabalin | Pregabalin | 35 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 34 | 12 |
| Mupirocin | Mupirocin | 34 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Ketoconazole | Ketoconazole | 33 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | 13 |
| Atropine Sulfate | Atropine Sulfate | 32 | 21 |
| Prednisolone Acetate | Prednisolone Acetate | 32 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 31 | 13 |
| Ozempic | Semaglutide | 31 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 31 | suppressed |
| Amantadine | Amantadine Hcl | 30 | suppressed |
| Cyclosporine | Cyclosporine | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Valsartan | Valsartan | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 23 |
| Desmopressin Acetate | Desmopressin Acetate | 29 | suppressed |
| Lidocaine | Lidocaine | 29 | 11 |
| Rivastigmine | Rivastigmine | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 17 |
| Prezista | Darunavir | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 18 |
| Lidocaine Hcl | Lidocaine Hcl | 25 | 16 |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 24 | 20 |
| Glipizide | Glipizide | 24 | suppressed |
| Mitigare | Colchicine | 24 | suppressed |
| Acetazolamide | Acetazolamide | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Ingrezza | Valbenazine Tosylate | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 23 | suppressed |
| Oxycontin | Oxycodone Hcl | 23 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 23 | suppressed |
| Rytary | Carbidopa/Levodopa | 23 | suppressed |
| Acetic Acid | Acetic Acid | 22 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 22 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Vraylar | Cariprazine Hcl | 21 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 16 |
| Nucynta | Tapentadol Hcl | 18 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 18 | suppressed |
| Calcium Acetate | Calcium Acetate | 17 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 17 | 14 |
| Celecoxib | Celecoxib | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Ongentys | Opicapone | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 16 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 11 |
| Scopolamine | Scopolamine | 16 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 15 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 12 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 15 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 15 | 13 |
| Calcitriol | Calcitriol | 14 | suppressed |
| Clotrimazole | Clotrimazole | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | suppressed |
| Hemady | Dexamethasone | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Ritonavir | Ritonavir | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Dapsone | Dapsone | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Procrit | Epoetin Alfa | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $143.05 · 6 records | Neurocrine BioSciences, Inc. | AUSTEDO XR, INGREZZA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Neurocrine BioSciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error